Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

3m Cavilon Durable Barrier

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 13000 mg/1 L
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
December 9, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 13000 mg/1 L
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
December 9, 2025
Manufacturer
Solventum US LLC
NDC root
17518-030
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (3 NDCs)
Packaging & NDC Codes (3)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Cavilon™ is a durable barrier cream designed to protect at-risk skin from damage associated with incontinence. It contains 1.3% dimethicone (a skin protectant) that helps to moisturize and condition dry skin while forming a protective barrier that resists wash-off. This cream is fragrance-free and paraben-free, making it suitable for sensitive skin.

By using Cavilon™, you can help shield your skin from the effects of incontinence, ensuring that it remains healthy and protected. Its unique formulation also allows for tape to stick effectively, making it a practical choice for those needing additional skin protection.

Uses

You can use this product to help protect your skin if you are at risk of damage due to incontinence and its related symptoms. It is designed to provide a barrier that helps keep your skin safe from irritation and discomfort associated with these conditions.

Rest assured, there are no known teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects associated with this product. This makes it a safe option for those who need it.

Dosage and Administration

To use 3M™ Cavilon™ Durable Barrier Cream effectively, start by gently cleansing the affected area of your skin. Once the skin is clean, apply the cream sparingly, ensuring that you cover the entire area that needs protection. It’s important to use just enough cream; if you notice that the area feels oily, you may have applied too much.

You can repeat this application as necessary, depending on your needs. This cream is designed to provide a protective barrier, so feel free to use it whenever you need to maintain skin health.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You may experience some side effects while using this medication. Allergic reactions can occur in sensitive individuals, so it's important to be aware of any unusual symptoms. Skin reactions are also possible, which may include redness, irritation, rash, or contact dermatitis (a skin reaction caused by contact with a substance). Additionally, if you apply too much cream, you might notice an oily feeling on your skin.

While these reactions can happen, there are no specific details about how often or how severe they may be. If you notice any concerning symptoms, it's best to consult with your healthcare provider.

Warnings and Precautions

It's important to follow the directions and warnings provided on the outer label or carton of your medication. This will ensure you understand how to use it safely and effectively.

While specific laboratory tests and emergency help instructions are not detailed here, you should always be aware of any unusual symptoms you may experience. If you notice anything concerning, stop taking the medication and contact your doctor immediately for guidance. Your health and safety are the top priority, so don't hesitate to seek help if needed.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical attention.

In case of an emergency, you should call your local emergency services or go to the nearest hospital. Always keep your medications in their original packaging and follow the prescribed dosage to minimize the risk of an overdose. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

There is currently no specific information available about the use of 3M Cavilon Durable Barrier Dimethicone Cream during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the drug insert.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any new products, including creams and ointments, to ensure they are safe for you and your baby.

Lactation Use

Currently, there is no specific information available about the use of 3M Cavilon Durable Barrier Dimethicone Cream for nursing mothers or its effects during breastfeeding. This means that if you are breastfeeding, you should consult your healthcare provider for personalized advice regarding the use of this cream. They can help you understand any potential risks or considerations for both you and your baby. Always prioritize open communication with your healthcare team to ensure the best outcomes for you and your infant.

Pediatric Use

Currently, there is no specific information available regarding the use of 3M Cavilon Durable Barrier Cream in children. This means that there are no recommended ages, dosage differences, or safety concerns outlined for pediatric (children's) use. If you are considering this product for a child, it is important to consult with a healthcare professional to ensure it is appropriate and safe for their specific needs. Always prioritize your child's health and well-being by seeking expert advice when using any medical products.

Geriatric Use

While there is no specific information about the use of 3M Cavilon Durable Barrier Cream in older adults, it’s important to approach its use with caution. Since the drug insert does not mention any dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can provide guidance tailored to your individual health needs and any potential considerations related to age. Always prioritize safety and ensure that any new product fits well with your overall care plan.

Renal Impairment

If you have kidney problems, it's important to know that the drug insert for 3M Cavilon Durable Barrier Cream does not provide specific information about dosage adjustments, special monitoring, or safety considerations for your condition. This means that there are no tailored guidelines for how this product may affect you if you have renal impairment (kidney issues).

Before using this cream, it’s a good idea to consult with your healthcare provider to ensure it’s safe for you, especially since individual health needs can vary. Your doctor can help determine the best approach based on your specific situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert for 3M Cavilon Durable Barrier - dimethicone cream does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this cream should be used if you have hepatic impairment (issues with liver function).

Before using this product, it’s a good idea to consult with your healthcare provider to ensure it’s safe for you, especially if you have any concerns about your liver health. They can provide personalized advice based on your medical history and current condition.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 15°C to 30°C (59°F to 86°F). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal.

Additional Information

The medication is administered topically, meaning it is applied directly to the skin. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences. If you have any specific questions or concerns about using this medication, it's best to consult with your healthcare provider.

FAQ

What is Cavilon™?

Cavilon™ is a durable barrier cream designed to protect at-risk skin from damage associated with incontinence and related symptoms.

What are the key ingredients in Cavilon™?

Cavilon™ contains Dimethicone Cream NF Skin Protectant 1.3% (w/w), which helps moisturize and condition dry skin while providing a protective barrier.

How should I apply Cavilon™?

Gently cleanse the skin as required, then apply Cavilon™ sparingly to cover the entire affected area. Repeat as necessary, but if the cream feels oily, you may have applied too much.

Are there any contraindications for using Cavilon™?

No contraindications are listed for Cavilon™.

What are the possible side effects of Cavilon™?

Possible side effects include allergic reactions in sensitive individuals, skin reactions like redness, irritation, rash, and contact dermatitis, as well as an oily feeling if too much cream is applied.

Is Cavilon™ safe to use during pregnancy?

No specific information regarding the use of Cavilon™ during pregnancy is provided, but it is noted that there are no teratogenic effects mentioned.

How should I store Cavilon™?

Store Cavilon™ between 15°C to 30°C (59°F to 86°F) to maintain its effectiveness.

Can Cavilon™ be used on children or elderly patients?

The drug insert does not provide specific information regarding pediatric or geriatric use, including safety concerns or dosage adjustments.

Packaging Info

Below are the non-prescription pack sizes of 3m Cavilon Durable Barrier (dimethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for 3m Cavilon Durable Barrier.
Details

Drug Information (PDF)

This file contains official product information for 3m Cavilon Durable Barrier, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the protection of at-risk skin from damage associated with incontinence and related symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should gently cleanse the skin as required prior to application. 3M™ Cavilon™ Durable Barrier Cream should be applied sparingly to cover the entire affected area. The application may be repeated as necessary to maintain effectiveness. Care should be taken to avoid excessive application; if the cream feels oily upon touch, it indicates that too much has been applied.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals are advised to refer to the outer label or carton for comprehensive directions regarding use, as well as detailed warnings and precautions associated with the product.

It is imperative to adhere to the general precautions outlined on the outer label or carton to ensure safe and effective use. These precautions are critical in mitigating potential risks associated with the product.

In the event of an emergency, healthcare professionals should be prepared to provide immediate medical assistance and seek emergency medical help as necessary.

Should any adverse effects or concerns arise during the course of treatment, it is essential for patients to discontinue use and promptly contact their healthcare provider for further guidance.

For any specific laboratory tests or monitoring parameters related to the safe use of this product, please consult the relevant clinical guidelines or product literature, as this information was not specified in the provided text.

Side Effects

Adverse reactions may occur in patients using the product, with allergic reactions being a potential concern for sensitive individuals. Skin reactions have been reported, including redness, irritation, rash, and contact dermatitis. Additionally, some patients may experience an oily feeling if an excessive amount of cream is applied.

No specific frequency or severity descriptors have been provided for these reactions, indicating that while they may occur, their occurrence rates and seriousness are not clearly defined. It is important for healthcare providers to monitor patients for these adverse reactions and manage them accordingly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of 3m Cavilon Durable Barrier (dimethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for 3m Cavilon Durable Barrier.
Details

Pediatric Use

There is no specific pediatric use information, recommended ages, dosing differences, safety concerns, or special precautions for children provided in the drug insert for 3M Cavilon Durable Barrier Cream. Therefore, healthcare professionals should exercise caution when considering the use of this product in pediatric patients, as the safety and efficacy in this population have not been established.

Geriatric Use

Elderly patients may not have specific information regarding the use of 3M Cavilon Durable Barrier Cream, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when administering this product to geriatric patients.

Due to the absence of clinical findings or recommendations tailored to this population, it is advisable for healthcare providers to closely monitor elderly patients for any adverse effects or unexpected reactions when using this cream. Individual patient assessment and clinical judgment should guide the use of this product in geriatric patients.

Pregnancy

There is no specific information regarding the use of 3M Cavilon Durable Barrier Dimethicone Cream in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions related to the use of this product during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for 3M Cavilon Durable Barrier Dimethicone Cream. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not established. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for 3M Cavilon Durable Barrier Cream. Healthcare professionals should exercise caution and consider the lack of data when prescribing this product to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of 3M Cavilon Durable Barrier - dimethicone cream. The prescribing information does not provide any recommendations regarding dosage adjustments, special monitoring, or precautions for individuals with compromised liver function. Therefore, healthcare professionals should exercise clinical judgment when considering the use of this product in patients with hepatic impairment, as no specific data is available to guide treatment decisions in this population.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to gently cleanse the affected skin area as needed before application. It is important to apply 3M™ Cavilon™ Durable Barrier Cream sparingly to ensure that the entire affected area is covered. Patients should be informed that the application may be repeated as necessary to maintain effectiveness.

Providers should also instruct patients to monitor the amount of cream applied; if the cream feels oily, it indicates that too much has been used. Additionally, patients should be made aware of the proper storage conditions for the product, which should be kept between 15°C to 30°C (59°F to 86°F).

Finally, healthcare providers should remind patients to refer to the outer label or carton for complete directions for use, as well as any warnings and precautions associated with the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 15°C to 30°C (59°F to 86°F) to maintain its efficacy and stability. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs must be observed to prevent any compromise to the product's integrity during storage and transportation.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for 3m Cavilon Durable Barrier, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for 3m Cavilon Durable Barrier, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.